Overview

Study to Evaluate the Effect of Food on the Pharmacokinetics of a BGB-3111 in Healthy Subjects

Status:
Completed
Trial end date:
2016-07-21
Target enrollment:
Participant gender:
Summary
Phase 1 study in healthy subjects to determine the effect of food on the pharmacokinetics of BGB-3111.
Phase:
Phase 1
Details
Lead Sponsor:
BeiGene
Treatments:
Zanubrutinib